Consolidated Statements of Changes in Equity - USD ($) $ in Thousands	Total	Common Stock	Paid-in Capital	Redeemable Perpetual Preferred Stock	Distributions in Excess of Accumulated Earnings	Accumulated Other Comprehensive Income/(Loss)	Non-controlling Interests – Common OP Units
Beginning balance at Dec. 31, 2023	$ 1,498,621	$ 1,917	$ 1,644,319	$ 0	$ (223,576)	$ 6,061	$ 69,900
Increase (Decrease) in Stockholders' Equity
Issuance of Common Stock through employee stock purchase plan	382		382
Compensation expenses related to restricted stock and stock options	1,716		1,716
Repurchase of Common Stock or Common OP Units	(1,908)		(1,908)
Adjustment for Common OP Unitholders in the Operating Partnership	0		58				(58)
Adjustment for fair market value of swap	(781)					(781)
Consolidated net income	115,271				109,905		5,366
Distributions	(93,398)				(89,050)		(4,348)
Other	(157)		(157)
Ending balance at Mar. 31, 2024	1,519,746	1,917	1,644,410	0	(202,721)	5,280	70,860
Beginning balance at Dec. 31, 2023	1,498,621	1,917	1,644,319	0	(223,576)	6,061	69,900
Increase (Decrease) in Stockholders' Equity
Adjustment for fair market value of swap	(769)
Ending balance at Jun. 30, 2024	1,510,294	1,917	1,646,160	0	(213,486)	5,292	70,411
Beginning balance at Mar. 31, 2024	1,519,746	1,917	1,644,410	0	(202,721)	5,280	70,860
Increase (Decrease) in Stockholders' Equity
Issuance of Common Stock through employee stock purchase plan	382		382
Compensation expenses related to restricted stock and stock options	1,767		1,767
Adjustment for Common OP Unitholders in the Operating Partnership	0		(76)				76
Adjustment for fair market value of swap	12					12
Consolidated net income	82,127			8	78,297		3,822
Distributions	(93,417)			(8)	(89,062)		(4,347)
Other	(323)		(323)
Ending balance at Jun. 30, 2024	1,510,294	1,917	1,646,160	0	(213,486)	5,292	70,411
Beginning balance at Dec. 31, 2024	1,823,786	1,962	1,951,430	0	(214,979)	2,303	83,070
Increase (Decrease) in Stockholders' Equity
Issuance of Common Stock through employee stock purchase plan	391		391
Compensation expenses related to restricted stock and stock options	1,771		1,771
Repurchase of Common Stock or Common OP Units	(2,258)		(2,258)
Adjustment for Common OP Unitholders in the Operating Partnership	0		118				(118)
Adjustment for fair market value of swap	(1,629)					(1,629)
Consolidated net income	114,393				109,192		5,201
Distributions	(103,128)				(98,439)		(4,689)
Other	(61)		(61)
Ending balance at Mar. 31, 2025	1,833,265	1,962	1,951,391	0	(204,226)	674	83,464
Beginning balance at Dec. 31, 2024	1,823,786	1,962	1,951,430	0	(214,979)	2,303	83,070
Increase (Decrease) in Stockholders' Equity
Adjustment for fair market value of swap	(4,313)
Ending balance at Jun. 30, 2025	1,812,952	1,962	1,953,854	0	(222,992)	(2,010)	82,138
Beginning balance at Mar. 31, 2025	1,833,265	1,962	1,951,391	0	(204,226)	674	83,464
Increase (Decrease) in Stockholders' Equity
Exchange of Common OP Units for Common Stock	(1)	0	396				(397)
Issuance of Common Stock through employee stock purchase plan	355		355
Compensation expenses related to restricted stock and stock options	1,812		1,812
Adjustment for Common OP Unitholders in the Operating Partnership	0		40				(40)
Adjustment for fair market value of swap	(2,684)					(2,684)
Consolidated net income	83,493			8	79,708		3,777
Distributions	(103,148)			(8)	(98,474)		(4,666)
Other	(140)		(140)
Ending balance at Jun. 30, 2025	$ 1,812,952	$ 1,962	$ 1,953,854	$ 0	$ (222,992)	$ (2,010)	$ 82,138